Coronavirus Update: Regeneron's REGEN-COV Authorized For Prevention
Executive Summary
Regeneron's antibody cocktail gets emergency authorization for post-exposure prophylaxis from the US FDA. Daewoong's camostat shows efficacy in older patients in South Korean trial.